Neurovascular Embolization Devices Market is Expected to Account for More Than US$ 1,733.1 Mn, in Terms of Value, by 2028 end: Persistence Market Research

Friday, January 11, 2019 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, January 10, 2019 /PRNewswire/ --

Various government and non-profit

organizations are making efforts to spread awareness regarding brain aneurysm and other neurovascular conditions, which is projected to driving the growth of the neurovascular embolization devices market

The increasing awareness regarding neurovascular

disease, and technological advancements in the diagnostic techniques are expected to propel the demand for neurovascular embolization devices over the forecast period. As per the latest research by the company, the global neurovascular embolization devices market is expected to account for more than US$ 1,733.1 Mn, in terms of value, by 2028 end. The report on neurovascular embolization devices market further projects significant growth potential with average year-on-year growth rate estimated at 4.4% through 2028. This elevation in the growth graph of neurovascular embolization devices market is attributed to increasing demand for minimally invasive neurosurgical procedure for better patient outcomes.

     (Logo: https://mma.prnewswire.com/media/661339/Persistence_Market_Research.jpg )

It is claimed by the Brain Aneurysm Foundation that around 6 million people in the U.S. suffer from brain aneurysms, which is expected to fuel the adoption minimally invasive neurovascular procedure. More than 500,000 people worldwide die due to stroke and other disorders associated with cerebral aneurysms, which is also increasing the demand for neurovascular embolization devices. Intracranial aneurysm is prevalent in individuals younger than 60 years, as half out of the total mortality rate due to brain aneurysms comprises share of young individuals below age 50.

Request For Report Sample: https://www.persistencemarketresearch.com/samples/25969

It is been found by the Brain Aneurysm Foundation that about 15% of individuals possessing aneurysms in the neurovascular tract are very likely to have more than one aneurysm. This factor further increases the demand for neurovascular embolization devices from the individuals suffering from cerebral aneurysms. Neurovascular aneurysms if not treated can result in severe consequences of neurological defects and permanent impairment of cognitive functions in the absence of neurovascular embolization devices. The observations of these outcomes from brain aneurysms is also projected to fuel the demand for neurovascular embolization devices over the forecast period.

Neurovascular embolization devices are majorly adopted by hospitals owing to the requirement of high-end technological devices for the purpose of visualization, navigation, precision and complex nature of the surgery. The outpatient centers segment is projected to grow at a CAGR of 4.8% over the forecast period due to increasing demand for minimally invasive surgeries.

With significant presence of key players and high healthcare expenditure, North America is projected to be the dominant regional market for neurovascular embolization devices over the forecast period. Asia Pacific neurovascular embolization devices market is projected to grow at a CAGR of 5.2% due to growing awareness regarding brain aneurysms and other neurovascular diseases as well as significant presence of key manufacturers.

The company has segmented the global neurovascular embolization devices market based on product type, end user and region. In terms of revenue, the embolization devices product type segment of the neurovascular embolization devices market is expected to hold significant share and grow at a high CAGR of 4.9% in the global neurovascular embolization devices market over the forecast period. Flow diversion stents segment in the neurovascular embolization devices market is also expected to grow at a significant CAGR owing to the low associated risks and their growing adoption by the end users. Aneurysm clips segment in the neurovascular embolization devices market is estimated to contribute 2.4% market share in the terms of revenue. These devices have witness significant decrease in demand due to invasive nature of the treatment.

Neurovascular Embolization Devices Market Segmentation by Key Players - ey players, such as Johnson and Johnson Services, Inc., Terumo Corporation, Stryker Corporation and Medtronic plc: https://www.persistencemarketresearch.com/market-research/neurovascular-embolization-devices-market.asp

Additionally, the hospital end-use segment in the neurovascular embolization devices market is predicted to exhibit growth by 4.2% CAGR during the forecast period. However, outpatient Centres hold key growth opportunity due to emergence of minimally invasive treatment modalities such as embolization coils, liquid embolic systems. North America neurovascular embolization devices market is estimated to create an incremental opportunity of US$ 229.7 Mn between 2018 and 2028.

The report tracks some of the key companies operating in the neurovascular embolization devices market, including Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A., Terumo Corporation, and Johnson and Johnson Services, Inc.

Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/methodology/25969

More from PMR's Life Sciences & Transformational Health Intelligence:

Small Joint Replacement Market Segmentation By product type - ankle replacement, digits replacement, elbow replacement and wrist replacement; end user - hospitals and outpatient centers: https://www.persistencemarketresearch.com/market-research/small-joint-replacement-market.asp

Oral Hygiene Products Market Segmentations By Product Type - toothpaste, toothbrush, mouth wash/rinse, floss, teeth whitening, orthodontic wax and denture cleansers & fixatives; By Indication - dental caries, gingivitis, halitosis, periodontitis and Peri-implantitis: https://www.persistencemarketresearch.com/market-research/oral-hygiene-products-market.asp

Facial Bone Contouring Market Segmentation By Surgery Type - Zygomatic bone surgery, Mentoplasty & Genioplasty, Rhinoplasty and Maxilla & Mandible surgery; By Region - North America, Latin America, Europe, Asia-Pacific (APAC), and the Middle East & Africa (MEA): https://www.persistencemarketresearch.com/market-research/facial-bone-contouring-market.asp

Persistence Market Research Overview 

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: sales@persistencemarketresearch.com  

PMR Latest News:  https://www.persistencemarketresearch.com/news

SOURCE Persistence Market Research Pvt. Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store